• About us
• Contact

Advertisement

Organisation › Details

PerkinElmer (Group)

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $1.7 billion in 2010, has about 6,200 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. *

 

	Start	2001-07-15 existent
	Industry	analytical instrument
	Industry 2	laboratory equipment and instruments
	Person	Friel, Robert F. (PerkinElmer 200802– CEO before COO before President Life+Analytical joined 1999 as CFO)
	Region	Waltham, MA
	Country	United States (USA)
	Street	940 Winter Street
	City	02451 Waltham, MA
	Tel	+1-781-663-6900
		Address record changed: 2020-12-02
Basic data	Employees	H: 10,001 to 50,00 (2019-02-22)
	Currency	USD
	Annual sales	2,777,996,000 (revenue, consolidated (2018) 2018-12-31)
	Profit	237,927,000 (2018-12-31)
	Cash	163,111,000 (2018-12-31)
		* Document for »About Section«:
		Record changed: 2023-07-10

Advertisement

More documents for PerkinElmer (Group)

• [1] CN Bio Innovations Ltd.. (3/14/23). "Press Release: CN Bio Appoints Deepak Singh as Vice President of Sales and Marketing". Cambridge....
• [2] CN Bio Innovations Ltd.. (12/19/22). "Press Release: CN Bio Appoints Dr Paul Brooks as Chief Executive Officer". Cambridge....
• [3] PerkinElmer, Inc.. (6/22/21). "Press Release: PerkinElmer Agrees to Acquire Viral Vector Gene Delivery Leader Sirion Biotech". Waltham, MA....
• [4] PerkinElmer, Inc.. (5/17/21). "Press Release: PerkinElmer to Acquire In-Vitro Diagnostics Company Immunodiagnostic Systems Holdings PLC". Waltham, MA....
• [5] PerkinElmer, Inc.. (5/12/21). "Press Release: PerkinElmer Expands Cell Biology Leadership with Agreement to Acquire Nexcelom Bioscience". Waltham, MA....
• [6] Congenica Ltd.. (4/6/21). "Press Release: Congenica Appoints Jayesh Pankhania as Chief Financial Officer". Cambridge....
• [7] PerkinElmer, Inc.. (1/7/21). "Press Release: PerkinElmer to Acquire Oxford Immunotec Global plc". Waltham, MA & London....
• [8] Sirion Biotech GmbH. (1/7/21). "Press Release: Sirion Biotech GmbH Licensed Its LentiBoost Transduction Technology to Cellectis". Munich & Cambridge, MA....
• [9] PerkinElmer, Inc.. (11/2/20). "Press Release: PerkinElmer to Acquire Cell Engineering Company Horizon Discovery for $383 Million (£296 Million)". Waltham, MA....
• [10] Sirion Biotech GmbH. (10/6/20). "Press Release: Mustang Bio Licenses LentiBOOST Technology from Sirion Biotech for the Development of MB-207 Lentiviral Gene Therapy". Worcester, MA & Martinsried....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.